Company intelligence / Profile preview

HillMed

Houston, Texas, United Stateshillmed.org ↗

Ownership: Private
Development stage: Clinical

Overview

HillMed is developing three novel medical devices aimed at improving the diagnosis, home care, and interventional treatment of chronic pelvic pain and related neuromuscular disorders. Their technologies include a clinician-worn EMG quantification device for digital exams, an at-home Bluetooth-enabled muscle retraining tool, and a targeted chemo-denervation system using neurotoxins such as Botox. Clinical results have not been published; products are in development.

Therapeutic areas: NeurologyWomen's Health
Modalities: Device (medical devices for diagnostics and therapy)
Industry: Physiological Monitoring

Drug pipeline

1 asset

PelviMap System

Clinical

Indications: Chronic pelvic pain

Beyond the preview

Go deeper on HillMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HillMed.

Explore the full profile